Evidence map›Paper›PMID 26488332›Full record

Trial reportCancer2016

Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.

Beverly B Green, Melissa L Anderson, Jessica Chubak, Sharon Fuller, Richard T Meenan, Sally W Vernon

Registry-linked trialOpen access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00697047 (Systems of Support to Increase Colon Cancer Screening and Follow-up), which is not on this map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00697047 nacompletednot on this map

Systems of Support to Increase Colon Cancer Screening and Follow-up

TypeinterventionalSponsorKaiser PermanenteRan2008 to 2019Enrolled4,653ConditionsColorectal CancerArmsAutomated Mailing, Automated Mailing Plus Assisted, Auto Plus Assisted Plus Navigation
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. What Multilevel Interventions Do We Need to Increase the Colorectal Cancer Screening Rate to 80%?Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Beverly B GreenGroup Health Permanente, Seattle, Washington.
Melissa L AndersonGroup Health Research Institute, Seattle, Washington.
Jessica ChubakGroup Health Research Institute, Seattle, Washington.
Sharon FullerGroup Health Research Institute, Seattle, Washington.
Richard T MeenanCenter for Health Research, Kaiser Permanente Northwest, Portland, Oregon.
Sally W VernonSchool of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas.
Kaiser Permanente Washington Health Research Institute · USKaiser Permanente · USThe University of Texas Health Science Center at Houston · USUniversity of Washington · US

Funding

Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-upR01CA121125 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI GREEN, BEVERLY BETH · 2007 to 2017
$8.0M
NCI NIH HHS R01 CA121125NCI NIH HHS R01CA121125
6 · The paper itself

Abstract

backgroundThe current study was conducted to determine the effect of continuing a centralized fecal occult blood test (FOBT) mailed program on screening adherence.

methodsA patient-level randomized controlled trial was conducted in 21 patient-centered medical home primary care clinics between January 2010 and November 2012. A total of 2208 patients ranging in age from 52 to 75 years in a substudy of the Systems of Support to Increase Colon Cancer Screening and Follow-Up (SOS) trial were randomized at year 3 to continued automated interventions (Continued group), which included mailed information regarding colorectal cancer (CRC) screening choices, and were mailed stool kit tests or to a group in which interventions were stopped (Stopped group). The main outcomes and measures were the completion of CRC screening in year 3 and by subgroup characteristics, respectively.

resultsAdherence to CRC screening in year 3 was found to be significantly higher in patients in the Continued group compared with those in the Stopped group (53.3% vs 37.3%; adjusted net difference, 15.6% [P<.001]). This difference was entirely due to greater completion of FOBT (adjusted net difference, 18.0% [P<.001]). Year 3 CRC screening rates were highest in patients in the Continued group completing FOBT in both years 1 and 2 (77.2%), followed by patients completing only 1 FOBT in 1 of the 2 years (44.6%), with low rates of CRC testing reported among patients not completing any FOBT within the first 2 years (18.1%).

conclusionsA centralized mailed FOBT CRC screening program continued to be more effective than patient-centered medical home usual-care interventions, but only for those patients who had previously completed FOBT testing. Research is needed regarding how to engage patients not completing CRC testing after being mailed at least 2 rounds of FOBT tests. Cancer 2016;122:312-321. © 2015 American Cancer Society.

Indexed as

Occult BloodReminder SystemsAgedAge FactorsColorectal NeoplasmsEarly Detection of CancerFecesFemaleFollow-Up StudiesHumansMaleMass ScreeningMiddle AgedPatient-Centered CarePatient CompliancePostal Servicecolonoscopycolorectal cancer screeningcomplete diagnostic evaluationnavigation

Identifiers

PMID26488332
PMCPMC4868396
OpenAlexW2106917428

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.